Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Blood|January 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcomeLorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, et al.
Annals of the Rheumatic Diseases|October 27, 2023
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centresMatthias Dreher, Torsten Witte, Kirsten Hoeper, et al.
The Lancet. Oncology|September 24, 2011
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) GroupMichael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, et al.
Frontiers in Immunology|December 31, 2021
<i>HLA-DRB3/4/5</i> Matching Improves Outcome of Unrelated Hematopoietic Stem Cell TransplantationChrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, et al.
Bone Marrow Transplantation|July 8, 2022
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantationChrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, et al.
Frontiers in Immunology|February 11, 2021
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter AnalysisDaphne Mytilineos, Chrysanthi Tsamadou, Christine Neuchel, et al.
Haematologica|July 18, 2020
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphomaLorenz Thurner, Sylvia Hartmann, Moritz Bewarder, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER TrialGerhard Held, Lorenz Thurner, Viola Poeschel, et al.
Lancet (London, England)|December 24, 2019
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trialViola Poeschel, Gerhard Held, Marita Ziepert, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER StudyLorenz Thurner, Marita Ziepert, Christian Berdel, et al.
Pageof 3